Two well-known and highly respected authorities on performance-enhancing substance use in sport and exercise have assembled the contributions of leading experts in the field. The result is the most comprehensive, up-to-date text available on the use and abuse of performance-enhancing substances among athletes today.
This authoritative and heavily referenced book includes everything from anabolics and stimulants to gene transfer therapy and beyond. It presents the following:
· The history of doping in sport and exercise
· The latest clinical and scientific research and reference material available concerning the use and abuse of performance-enhancing substances among professional, Olympic-level, college, and high school athletes
· Important developments in the legal aspects of use in sport and exercise
· New information related to substance and drug testing
· The issues surrounding assessment of the efficacy of performance-enhancing substances
· Information on the new and emerging technologies—such as gene transfer therapy and new drug delivery systems—that have potential for abuse by athletes
No other text offers analyses of the ergogenic efficacy of nearly every substance currently used and abused by athletes today. It paints a complete picture of performance-enhancing substances and related issues. It gathers essential studies, data, and commentary not available elsewhere in one resource. Performance-Enhancing Substances in Sport and Exercise features 29 chapters covering dozens of substances, thousands of references, and chapters devoted to the history and future of performance-enhancing substances in sport and exercise, the determination of the efficacy of substances, drug testing, and legal issues
Foreword
Preface
Part I Introduction
Chapter 1. History of Doping in Sport
Charles E. Yesalis and Michael S. Bahrke
Chapter 2. Determining the Efficacy of Performance-Enhancing Substances
Stan Reents
Part II Anabolics
Chapter 3. Anabolic-Androgenic Steroids
Michael S. Bahrke and Charles E. Yesalis
Chapter 4. Beta-2 Agonists
Gordon S. Lynch
Chapter 5. Growth Hormone: Physiological Effects of Exogenous Administration
William J. Kraemer, Bradley C. Nindl, and Martyn R. Rubin
Chapter 6. Physiological Effects of Testosterone Precursors
William J. Kraemer, Martyn R. Rubin, Duncan N. French, and Michael R. McGuigan
Chapter 7. Human Chorionic Gonadotropin
R. Craig Kammerer
Part III Blood Doping
Chapter 8. Blood Doping
Björn T. Ekblom
Chapter 9. Erythropoietin
Björn T. Ekblom
Part IV Diuretics
Chapter 10. Diuretics
Lawrence E. Armstrong
Part V Narcotic and Non-Narcotic Analgesics and Depressants
Chapter 11. Narcotic Analgesics and Athletic Performance
Dean F. Connors and John Sudkamp
Chapter 12. Nonsteroidal Anti-Inflammatory Drugs and Corticosteroids
Louis C. Almekinders
Chapter 13. Hypnotics, Anxiolytics, and Neuroleptics
Michel Bourin, Danièle Bentué-Ferrer, Hervé Allain, and Pierre Rochcongar
Chapter 14. Beta-Adrenergic Antagonists
Kurt A. Mossberg and Claire Peel
Part VI Nutritional Ergogenic Aids
Chapter 15. Macronutrients and Metabolic Intermediates
Ellen Coleman and Suzanne Nelson Steen
Chapter 16. Creatine As an Ergogenic Supplement
J. David Branch and Melvin H. Williams
Chapter 17. Sodium Bicarbonate
Michael Webster
Chapter 18. Herbals As Ergogenic Aids
Melvin H. Williams and J. David Branch
Part VII Social/Recreational Drugs
Chapter 19. Alcohol Use in Sport and Exercise
Robert D. Stainback and Rachelle Jansevics Cohen
Chapter 20. Cannabis: Clinical Pharmacology and Performance Effects in Humans
Stephen J. Heishman
Part VIII Stimulants
Chapter 21. Amphetamines
Steven B. Karch
Chapter 22. Caffeine
Lawrence L. Spriet
Chapter 23. Cocaine
Robert K. Conlee
Chapter 24. Ephedrine As an Ergogenic Aid
Eric S. Rawson and Priscilla M. Clarkson
Part IX Miscellaneous Substances
Chapter 25. Gamma-Hydroxybutyric Acid
Vincenzo R. Sanguineti and Marion Rudin Frank
VChapter 26. Future/Designer Drugs: Emerging Science and Technologies
Gary I. Wadler
Part X Drug Testing
Chapter 27. Drug Testing in Sport and Exercise
R. Craig Kammerer
Chapter 28. Form Over Substances: The Legal Context of Performing-Enhancing Substances
Charles E. Petit
Part XI Summary
Chapter 29. Issues, Concerns, and the Future of Performance-Enhancing Substances in Sport and Exercise
Michael S. Bahrke and Charles E. Yesalis
Appendix: Resources
Index
About the Editors
About the Contributors
Reference for exercise scientists, sports medicine specialists, sport administrators, coaches, athletes, and legal experts
Michael Bahrke, PhD, joined Human Kinetics Publishers in 1994 and is an acquisitions editor in the scientific, technical, and medical division.
He was project director for an anabolic steroids research grant, one of the largest research projects ever funded by the National Institute on Drug Abuse (NIDA). He has published many scientific papers on performance-enhancing substances and has made presentations on the topic at numerous scientific meetings, including the American Psychiatric Association annual meeting and the International Conference on the Abuse and Trafficking of Anabolic Steroids, U.S. Drug Enforcement Administration.
Bahrke earned a PhD in sport psychology in 1977 from the University of Wisconsin at Madison. He is a fellow in the American College of Sports Medicine and a member of the European College of Sport Science. He is currently working with Dr. Yesalis on a new book for Human Kinetics, The History of Doping in Sport.
Charles Yesalis, ScD, is known worldwide for his research and teaching related to the nonmedical use of steroids and other performance-enhancing drugs. He is currently professor of health policy and administration and exercise and sport science at Pennsylvania State University.
Dr. Yesalis has authored and coauthored more than 70 journal articles and has also edited or coauthored three books concerning steroid usage. He is a frequent presenter at international conferences throughout North America and Europe. In addition, he has testified before the U.S. Congress and acted as a consultant for the U.S. Senate Judiciary Committee, Drug Enforcement Administration, NFL Players Association, Food and Drug Administration, and Centers for Disease Control and Prevention.
He earned a master's degree in public health from the University of Michigan and a doctoral degree from Johns Hopkins School of Hygiene and Public Health.
Subscribe to feed
